← Back to Search

Behavioural Intervention

BREAST-Q REACT Tool for Breast Surgery

N/A
Recruiting
Led By Jonas Nelson, MD, MPH
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
First breast cancer surgery
Female sex
Must not have
Cannot communicate in English
Recurrent breast cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Summary

"This trial is being conducted to see if using the BREAST-Q Real-time Engagement and Communication Tool (REACT) can improve the quality of life for people who have undergone breast surgery. The tool collects

Who is the study for?
This trial is for individuals undergoing routine breast conserving surgery or mastectomy. It aims to include those who are willing to use the BREAST-Q REACT tool, which involves completing questionnaires about their physical wellbeing and arm function before and after surgery.
What is being tested?
The study is testing the BREAST-Q REACT tool's effectiveness in improving patients' quality of life, doctor-patient communication, and medical care post-surgery. Participants will provide feedback on physical well-being and arm mobility through standard questionnaires.
What are the potential side effects?
Since this trial focuses on a feedback tool rather than a medication or surgical intervention, there are no direct side effects from the interventions being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having my first surgery for breast cancer.
Select...
I am female.
Select...
I am scheduled for breast surgery followed by reconstruction using implants or my own tissue.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot communicate in English.
Select...
My breast cancer has come back.
Select...
I am male.
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
feasibility of recruitment
Secondary outcome measures
feasibility of protocol delivery

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Participants in the intervention group will receive feedback using the BREAST-Q REACT tool from questionnaires completed before and after routine surgery, in addition to the usual way by discussing it with their surgeon.
Group II: Control groupActive Control1 Intervention
Participants in the control group will receive the usual feedback from questionnaires completed before and after routine surgery by discussing it with their surgeon

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,956 Previous Clinical Trials
595,496 Total Patients Enrolled
Jonas Nelson, MD, MPHPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
~40 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top